
BioAmber
3850 Annapolis Lane North, Suite 180, Plymouth, Minnesota, 55447, United States
Overview
BioAmber has developed a proprietary technology platform that combines industrial biotechnology, an innovative purification process and chemical catalysis to convert renewable feedstocks into commercial chemicals. Its products include bio-succinic acid and derivatives intended for use in plastics, food additives and personal care products. The company completed a $30M Series C financing to support its growth and commercialization. BioAmber is collaborating with LANXESS to develop renewable, phthalate-free succinic-based plasticizers and expected to begin sampling those plasticizers in 2012. The two companies are also working together on establishing a world-scale bio-succinic acid manufacturing facility in Sarnia, Ontario, where LANXESS will provide the site, utilities and services. The company is led by CEO Jean-Francois Huc and has added LANXESS’ Jorge Nogueira to its board as part of the investment and collaboration. BioAmber Inc. is described in the article as a clean‑technology company whose technologies involve chemical engineering, catalysts, yeasts and bacteria. The company operates in the renewable chemistry/clean tech sector. On April 15, 2011 BioAmber closed a $45 million growth equity financing that was announced May 4, 2011. The transaction was led by NAXOS Capital Partners, a Luxembourg‑based private equity firm focused on renewable chemistry and energy. Jeffer Mangels Butler & Mitchell LLP (JMBM) represented NAXOS as the lead investor; attorneys on the deal included David B. Stern, Robert Steinberg, Rod Berman and Craig Levine. JMBM noted the deal presented cross‑border and intellectual property issues, reflecting the technical and IP‑intensive nature of BioAmber's technologies. DNP Green Technology is a late-stage bio-materials company preparing to commercialize bio-based succinic acid. The company will begin selling succinic acid in 2009 through its Bioamber joint venture with ARD. Bioamber’s plant was built at a cost of $27m and will produce bio-based succinic acid at commercial scale. The plant’s initial annual production capacity is 5,000,000 lbs. DNP Green recently completed a $12m equity funding round to support its operations and commercialization. The company maintains offices in Princeton, N.J., and Montreal and has a joint venture with ARD in Pomacle, France.
- Total raised
- $87M
- Funding rounds
- 3
- Latest round
- Series C
- Latest activity
- Feb 2012
Industries
- Biotechnology
- Chemical
- GreenTech
Recent funding
Series C
Feb 2012
$30M
Series B
May 2011
$45M
Equity
Oct 2009
$12M
Team
No current team members are available.